This announcement is a separate document:
圣达生物：浙江圣达生物药业股份有限公司2022年第三季度报告
Shengda Biotech: Zhejiang Shengda Biopharmaceutical Co., Ltd. report for the third quarter of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.